WebJun 24, 2010 · Concurrent other malignancy at other sites or previous other cancer within the last 5 years, with the exception of adequately treated in situ carcinoma of cervix uteri or basal or squamous cell carcinoma of the skin or a contralateral breast cancer. Serious uncontrolled intercurrent infections. Poor compliance. WebApr 1, 1993 · Pharmacological studies on breast cancer can be cited to Cisplatin [12] .Cisplatin is one of the factors used in chemotherapy; and yet, it is not always used to treat breast...
CISPLATIN + AZD-1775 In Breast Cancer - Full Text View - ClinicalTr…
WebCisplatin is a chemotherapy drug used to treat testicular, ovarian, bladder, head and neck, lung and cervical cancer. It may also be used to treat other cancers. It is best to read this information with our general information about chemotherapy and the … WebIn patients with breast cancer, cellular expression of COL1A1 was associated with ER/PR expression and metastasis status. The increased COL1A1 level was associated with poor survival, especially in patients with ER+ breast cancer. Patients with a high-level of COL1A1 showed better cisplatin-based chemotherapy response. configentity configentity
Cisplatin (chemotherapy drug) - Macmillan Cancer Support
WebApr 12, 2024 · The long-term prognosis for women with recurrent endometrial cancer is also poor. The combination of the chemotherapy drugs cisplatin and paclitaxel has long been … WebBreast Cancer using CISplatin and Gemcitabine . Protocol Code . BRAVGEMP. Tumour Group : Breast: Contact Physician : Dr. Susan Ellard: ELIGIBILITY: Progressive breast cancer after adjuvant anthracyclinebased chemotherapy. - Second or third line treatment of metastatic breast cancer after previous chemotherapy with WebNov 13, 2013 · Cisplatin and paclitaxel are active in triple-negative breast cancer (TNBC). Despite different mechanisms of action, effective predictive biomarkers to preferentially inform drug selection have not been identified. edgar allan poe story about the ticking clock